DIANNE M. PARROTTE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

COGNEX CORP

Filing Date Source Excerpt
2018-03-14 Dianne M. Parrotte, M.D., M.P.H., 68, was nominated to serve as a director in 2018. Since 1995, Dr. Parrotte has been an independent consultant to corporations, law firms and insurance companies on human resource matters involving employee health and wellness. She was a trustee of the Shillman Foundation from March 2000 until her resignation in February 2018. From 1989 until 1995, Dr. Parrotte was chief in charge of occupational health at Bath Iron Works (later acquired by General Dynamics). From 1982 to 1988, she was the on-site medical director at Polaroid Corporation. Dr. Parrotte served as a Cognex director from 1981, at the time of the Company’s incorporation, to 1982. In addition to numerous certifications and licenses, Dr. Parrotte holds an M.P.H. from the Medical College of Wisconsin, an M.D. from the Boston University School of Medicine and a B.A. from Boston University. She also completed the Penn State Executive Program. During the past five years, Dr. Parrotte has not served as a member of the Board of Directors of another publicly held company or of a registered investment company. We believe Dr. Parrotte’s qualifications for sitting on our Board of Directors include her experience with a wide range of human resource and organizational matters, as well as her significant knowledge of the history and culture of Cognex. Director Compensation Table—2017: No compensation reported.
2019-03-13 Dianne M. Parrotte, M.D., M.P.H., 69, has served as a director since 2018 following her election at the 2018 Annual Meeting of Shareholders. Details of Dr. Parrotte’s compensation are set forth under the heading “Director Compensation Table—2018.”
2020-03-13 Dianne M. Parrotte, M.D., M.P.H., 70, has served as a director since 2018. ... Dr. Parrotte holds an M.P.H. from the Medical College of Wisconsin, an M.D. from the Boston University School of Medicine and a B.A. from Boston University. ... The following table provides current committee membership information for each of the Board committees: ... Dianne M. Parrotte Compensation/Stock Option Committee Member. ... Director Compensation Table-2019 shows Dr. Parrotte received $56,350 in fees earned or paid in cash and $674,199 in option awards for a total of $730,549.
2021-03-23 Dianne M. Parrotte, M.D., M.P.H., 71, has served as a director since 2018. ... Dr. Parrotte holds an M.P.H. from the Medical College of Wisconsin, an M.D. from the Boston University School of Medicine and a B.A. from Boston University. ... The following table sets forth the compensation earned by or awarded to each Director who served on our Board of Directors in 2020, other than Dr. Shillman and Mr. Willett. ... Dianne M. Parrotte Fees Earned or Paid in Cash: $30,800, Option Awards: $424,534, All Other Compensation: $0, Total Compensation: $455,334.
2023-03-17 Dianne M. Parrotte, M.D., M.P.H., 73, has served as a director since 2018. She serves on the Compensation/Stock Option Committee, Audit Committee, and Nominating, Governance and Sustainability Committee. Director compensation total: $335,554.
2024-03-15 Dianne M. Parrotte, M.D., M.P.H., 74, has served as a Director since 2018. ... The following table sets forth the compensation earned by or awarded to each Director who served on our Board of Directors in 2023, other than Mr. Willett. ... Dianne M. Parrotte Fees Earned or Paid in Cash $72,000, Stock Awards $271,533, Total Compensation $343,533 ... The following table provides current committee membership information for each of the Board committees: Dianne M. Parrotte Compensation/Stock Option Committee, Audit Committee.
2025-03-14 Dianne M. Parrotte, M.D., M.P.H., 75, has served as a Director since 2018. ... The following table provides current committee membership information for each of the Board committees: ... Dianne M. Parrotte: Compensation/Stock Option Committee member, Audit Committee member. ... Director Compensation Table—2024: Dianne M. Parrotte total compensation $338,015.

Data sourced from SEC filings. Last updated: 2025-12-06